Anna Zlotina

Dr. Anna Zlotina

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2018 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
VFVeniamin Fishman
Veniamin Fishman
NBNariman Battulin
Nariman Battulin
MNMiroslav Nuriddinov
Miroslav Nuriddinov
AMAntonina Maslova
Antonina Maslova
AZAnna Zlotina
Anna Zlotina
AKAlla Krasikova
Alla Krasikova
How chromosomes are folded, spatially organized and regulated in three dimensions inside the cell nucleus are among the longest standing questions in cell biology. Genome-wide chromosome conformation capture (Hi-C) technique allowed identifying and characterizing spatial chromatin compartments in several mammalian species. Here, we present the first genome-wide analysis of chromatin interactions in chicken embryonic fibroblasts (CEF) and adult erythrocytes. We showed that genome of CEF is partitioned into topologically associated domains (TADs), distributed in accordance with gene density, transcriptional activity and CTCF-binding sites. In contrast to mammals, where all examined somatic cell types display relatively similar spatial organization of genome, chicken erythrocytes strongly differ from fibroblasts, showing pronounced A- and B- compartments, absence of typical TADs and formation of long-range chromatin interactions previously observed on mitotic chromosomes. Comparing mammalian and chicken genome architectures, we provide evidence highlighting evolutionary role of chicken TADs and their significance in genome activity and regulation.

23 September 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAnna Kostareva
Anna Kostareva
AKArtem Kiselev
Artem Kiselev
AGAlexandra Gudkova
Alexandra Gudkova
GFGoar Frishman
Goar Frishman
ARAndreas Ruepp
Andreas Ruepp
ESEugeniy Shlyakhto
Eugeniy Shlyakhto
Cardiomyopathies represent a rare group of disorders often of genetic origin. While approximately 50% of genetic causes are known for other types of cardiomyopathies, the genetic spectrum of restrictive cardiomyopathy (RCM) is largely unknown. The aim of the present study was to identify the genetic background of idiopathic RCM and to compile the obtained genetic variants to the novel signalling pathways using in silico protein network analysis. We used Illumina MiSeq setup to screen for 108 cardiomyopathy and arrhythmia-associated genes in 24 patients with idiopathic RCM. Pathogenicity of genetic variants was classified according to American College of Medical Genetics and Genomics classification. Pathogenic and likely-pathogenic variants were detected in 13 of 24 patients resulting in an overall genotype-positive rate of 54%. Half of the genotype-positive patients carried a combination of pathogenic, likely-pathogenic variants and variants of unknown significance. The most frequent combination included mutations in sarcomeric and cytoskeletal genes (38%). A bioinformatics approach underlined the mechanotransducing protein networks important for RCM pathogenesis. Multiple gene mutations were detected in half of the RCM cases, with a combination of sarcomeric and cytoskeletal gene mutations being the most common. Mutations of genes encoding sarcomeric, cytoskeletal, and Z-line-associated proteins appear to have a predominant role in the development of RCM.

1 June 2020 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
NSNatalia Smolina
Natalia Smolina
AKAleksandr Khudiakov
Aleksandr Khudiakov
AKAnastasiya Knyazeva
Anastasiya Knyazeva
AZAnna Zlotina
Anna Zlotina
KSKseniya Sukhareva
Kseniya Sukhareva
AKAnna Kostareva
Anna Kostareva

10 November 2012 in Chromosome Research
Verified
Journal Article
Closed access
PDF file
AZAnna Zlotina
Anna Zlotina
SGSvetlana Galkina
Svetlana Galkina
AKAlla Krasikova
Alla Krasikova
RCRichard P. M. A. Crooijmans
Richard P. M. A. Crooijmans
Martien GroenenMartien Groenen
Martien Groenen
SDSvetlana Deryusheva
Svetlana Deryusheva

10 November 2012 in Chromosome Research
Verified
Journal Article
Closed access
PDF file
AKAlla Krasikova
Alla Krasikova
TFTatsuo Fukagawa
Tatsuo Fukagawa
AZAnna Zlotina
Anna Zlotina

15 October 2020 in Genes
Verified
Journal Article
Open access
PDF file
JJJohn Jörholt
John Jörholt
YFYulya Fomicheva
Yulya Fomicheva
TVTatyana Vershinina
Tatyana Vershinina
AKArtem Kiselev
Artem Kiselev
AMAlexey Muravyev
Alexey Muravyev
AKAnna Kostareva
Anna Kostareva
Hypertrophic cardiomyopathy associated with damaging variants in the ALPK3 gene is a fairly recent discovery, and only a small number of patients have been described thus far. Here we present two additional patients with hypertrophic cardiomyopathy caused by biallelic variants in ALPK3. Genetic investigation was performed using a targeted gene panel consisting of known cardiomyopathy-associated genes and whole exome sequencing. The patients showed a large difference in the age of onset, and both presented with extracardiac features that are often seen in ALPK3 patients. The patient with the later onset showed milder extracardiac symptoms, such as decreased muscle tone and distal muscular dystrophy, but had fast progression of cardiac complications leading to the need of heart transplantation. This study further elucidates the variability of both symptoms and age of onset among these patients.